Skip to search.
 TSX Up 0.84% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

7.91 Down 0.13(1.60%) 2:52PM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:8.04
Open:8.06
Bid:7.99 x 1300
Ask:8.00 x 1900
1y Target Est:12.44
Beta:3.43
Next Earnings Date: 5-Aug-13KERX Earnings announcement
Day's Range:7.91 - 8.26
52wk Range:1.55 - 9.98
Volume:1,408,256
Avg Vol (3m):2,982,590
Market Cap:646.47M
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXDown 1.60%646.47M
PFZ.L 0.00%173.71B
GSK.LUp 0.53%83.39B
AZN.LUp 0.22%42.38B
JNJ.MXUp 0.01%3.00T

Key Statistics

Forward P/E (1 yr):99.88
P/S (ttm):93.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.32
Quarterly EPS Est (Jun-13) :-0.10
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.83

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback